指南与共识甲状腺疾病

美国甲状腺协会甲状腺结节与分化型甲状腺癌指南工作组对无侵袭性包裹性滤泡型甲状腺乳头状癌重新命名为具有乳头状核特征的非侵袭性滤泡性甲状腺肿瘤的审查与推荐

American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.
指南 / 共识 · Thyroid · 2017-02-21

美国甲状腺协会领导层要求指南工作组审查将无包膜或血管侵袭的包裹性滤泡型甲状腺乳头状癌(eFVPTC)重新分类为具有乳头状核特征的非侵袭性滤泡性甲状腺肿瘤(NIFTP)的建议。工作组评估了提出新分类的手稿及相关文献,建议将无侵袭性eFVPTC的组织病理学命名重新分类为NIFTP,基于中等质量证据,为弱推荐。工作组指出需要前瞻性研究来验证观察到的患者结局及对患者心理社会健康和经济的影响。

要点

  • 建议将无侵袭性包裹性滤泡型甲状腺乳头状癌重新分类为具有乳头状核特征的非侵袭性滤泡性甲状腺肿瘤(NIFTP)。
  • 该推荐基于中等质量证据,为弱推荐。
  • 需要前瞻性研究验证患者结局及对心理社会健康和经济的影响。

核心结论

  • 建议将无侵袭性eFVPTC的组织病理学命名重新分类为NIFTP,基于中等质量证据,为弱推荐。
  • 需要前瞻性研究验证观察到的患者结局及对患者心理社会健康和经济的影响。

研究设计与样本

  • 美国甲状腺协会领导层要求甲状腺结节与分化型甲状腺癌指南工作组审查、评论并就eFVPTC重新分类为NIFTP的建议提出推荐。
  • 工作组由2015年指南工作组成员组成,三名为被审查论文作者的工作组成员回避,并增加了四名病理学家和一名内分泌学家参与此次特定审查。
  • 评估了提出新分类的手稿及相关文献。

主要发现

  • 建议将无侵袭性eFVPTC重新分类为NIFTP,基于中等质量证据,为弱推荐。
  • 需要前瞻性研究验证观察到的患者结局及对患者心理社会健康和经济的影响。

关键数值与推荐

  • 建议将无侵袭性eFVPTC的组织病理学命名重新分类为NIFTP(弱推荐,基于中等质量证据)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要前瞻性研究验证观察到的患者结局及对患者心理社会健康和经济的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

American Thyroid Association (ATA) leadership asked the ATA Thyroid Nodules and Differentiated Thyroid Cancer Guidelines Task Force to review, comment on, and make recommendations related to the suggested new classification of encapsulated follicular variant papillary thyroid carcinoma (eFVPTC) without capsular or vascular invasion to noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). The task force consists of members from the 2015 guidelines task force with the recusal of three members who were authors on the paper under review. Four pathologists and one endocrinologist were added for this specific review. The manuscript proposing the new classification and related literature were assessed. It is recommended that the histopathologic nomenclature for eFVPTC without invasion be reclassified as a NIFTP, given the excellent prognosis of this neoplastic variant. This is a weak recommendation based on moderate-quality evidence. It is also noted that prospective studies are needed to validate the observed patient outcomes (and test performance in predicting thyroid cancer outcomes), as well as implications on patients' psychosocial health and economics.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Haugen BR, Sawka AM, Alexander EK, et al. American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. Thyroid. 2017. PMID: 28114862. doi:10.1089/thy.2016.0628

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。